Related references
Note: Only part of the references are listed.High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae
Nicole Wolter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Clinical impact of antibiotic resistance in respiratory tract infections
Keith P. Klugman
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Telithromycin use and spontaneous reports of hepatotoxicity
David D. Dore et al.
DRUG SAFETY (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model
E. Azoulay-Dupuis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Brief communication: Severe hepatotoxicity of telithromycin: Three case reports and literature review
KD Clay et al.
ANNALS OF INTERNAL MEDICINE (2006)
Telithromycin: A ketolide antibiotic for treatment of respiratory tract infections
JR Lonks et al.
CLINICAL INFECTIOUS DISEASES (2005)
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin
M Bosnar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro
MT Labro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae
JH Jorgensen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Ribosome affinity and the prolonged molecular postantibiotic effect of cethromycin (ABT-773) in Haemophilus influenzae
ZS Cao et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection
AM Ríos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi
KP Hunfeld et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro activity of ABT773, a new ketolide derivative exhibiting innovative microbiological properties against well-characterised antibiotic resistant pathogens in Italy
M Bozzolasco et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Bactericidal effect of cethromycin (ABT-773) in an immunocompetent murine pneumococcal pneumonia model
B Capitano et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae
N Miyashita et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain:: in vitro activities of telithromycin and cethromycin
MI Morosini et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Accumulation and activity of cethromycin (ABT-773) within human polymorphonuclear leucocytes
I García et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates:: Results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002
GG Zhanel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae
MR Hammerschlag et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Structural basis for the antibiotic activity of ketolides and azalides
F Schlünzen et al.
STRUCTURE (2003)
In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas
KB Waites et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides
WO Mason et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae:: correlation with extended MLSK phenotypes
JMT Hamilton-Miller et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model
MK Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Comparison of selection for mutants with reduced susceptibility to ABT-773, erythromycin and rifampicin in respiratory tract pathogens
AM Nilius et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila
R Jung et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Pharmacokinetics of ABT-773, a new semi-synthetic ketolide in neutropenic lung-infected mice: a population approach
DW Xuan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae
MM Neuhauser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens
ZK Ma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia
PH Edelstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Efficacies of ABT-773, a new ketolide, against experimental bacterial infections
MJ Mitten et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vitro activities of ABT-773, a new ketolide, against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis
EJC Goldstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide
AM Nilius et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria
DM Citron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents
KL Credito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model
MH Cynamon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Antipneumococcal activity of ABT-773 compared to those of 10 other agents
TA Davies et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Studies of the novel ketolide ABT-773:: Transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae
JO Capobianco et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae
S Strigl et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae
MR Hammerschlag et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae
TA Davies et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumonias
MR Hammerschlag et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
Share Paper
